Merck (MRK) Tops Q1 EPS by 20c; offers guidance

Merck (NYSE: MRK) reported Q1 EPS of ($1.28), $0.20 better than the analyst estimate of ($1.48). Revenue for the quarter came in at $16.29 billion versus the consensus estimate of $15.89 billion.

GUIDANCE:

Merck sees FY2026 EPS of $5.04-$5.16, versus the consensus of $5.11. Merck sees FY2026 revenue of $65.8-67 billion, versus the consensus of $66.493 billion.

For earnings history and earnings-related data on Merck (MRK) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• Fabrinet (FN) Tops Q4 EPS by 29c, Beats on Revenue; Offers Guidance
• Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance